Computational Toxicology: Endocrine Disrupting Effects of Lavender and Tea Tree Metabolites
Authors
Selvira Anandia Intan Maulidya , Baiq Risky Wahyu Lisnasari , Indra Purnomo , Tuhfatul Ulya , Wayan Cintya Ganes BudastraDOI:
10.29303/jbt.v25i2.9143Published:
2025-06-04Issue:
Vol. 25 No. 2 (2025): April-JuniKeywords:
endocrine disrupting chemicals; essential oil; lavender; tea treeArticles
Downloads
How to Cite
Downloads
Metrics
Abstract
While Lavandula angustifolia (lavender) and Melaleuca alternifolia (tea tree) are widely utilized in diverse products for their rich bioactive secondary metabolites, emerging evidence now fules concerns about their potential endocrine-disrupting activities. This study aimed to investigate the endocrine-disrupting potential of selected secondary metabolites from lavender and tea tree via an in silico molecular docking approach. Molecular interactions were evaluated against 18 human endrocine receptors using Endocrine Disruptome in silico tools and binding affinities were analyzed to assess potential toxicity. Docking analysis revealed that all lavender anda tea tree secondary metabolites have the potential to interact as androgen receptor antagonists, exhibiting minor, medium, and high probabilities of such activity. Additionally, more than 20% of lavender secondary metabolites and 10% of tea tree secondary metabolites are predicted to be capable of binding to the mineralocorticoid receptor, as well as thyroid receptors alpha and beta. These findings suggest a plausible mechanism by which these phytochemicals could exert endocrine-disruptor effects. In conclusion, the study provides preliminary computational evidence supporting the hypothesis that certain lavender and tea tree sceondary metabolites may act as endocrine-disrupting agents. Further in vitro and in vivo studies are warranted to assess their toxicological implications for long-term human exposure.
References
Afendi, F. M., Okada, T., Yamazaki, M., Hirai-Morita, A., Nakamura, Y., Nakamura, K., Ikeda, S., Takahashi, H., Altaf-Ul-Amin, M., Darusman, L. K., Saito, K., & Kanaya, S. (2012). KNApSAcK family databases: Integrated metabolite-plant species databases for multifaceted plant research. Plant and Cell Physiology, 53(2). https://doi.org/10.1093/pcp/pcr1 65
Aprianti, A., Hasrawati, A., & Mirawati (2024). Dosage forms and safety of Tea Tree (Melaleuca alternifolia) Oil in Cosmetics. Makassar Pharmaceutical Science Journal, 2(1), 169-181. https://doi.org/10.33096/mpsj.v2i1.193
Dornic, N., Ficheux, A. S., Roudot, A. C., Saboureau, D., & Ezzedine, K. (2016). Usage patterns of aromatherapy among the French general population: A descriptive study focusing on dermal exposure. Regulatory Toxicology and Pharmacology, 76, 87–93. https://doi.org/10.1016/j.yrtph.2016.01.016
Hawkins, J., Hires, C., Dunne, E., & Baker, C. (2020). The relationship between lavender and tea tree essential oils and pediatric endocrine disorders: A systematic review of the literature. Complementary Therapies in Medicine, 49. https://doi.org/10.1016/j.ctim.2019 .102288
Henley, D. V., & Korach, K. S. (2010). Physiological effects and mechanisms of action of endocrine disrupting chemicals that alter estrogen signaling. Hormones, 9(3), 191–205. https://doi.org/10.14310/horm.2002.1270
Jurowski, K., Niznik, T., Frydrych, A., Kobylarz, D., Noga, M., Krosniak, A., Fijatkowska, O., Swidniak, A. & Ahuja, V. (2025). Toxicological profile of Acovenoside A as an active pharmaceutical ingredient – prediction of missing key toxicological endpoints using in silico toxicology methodology. Chembo-Biological Interactions, 408, https://doi.org/10.1016/j.cbi.2025.111404
Kadmiel, M., & Cidlowski, J. A. (2013). Glucocorticoid receptor signaling in health and disease. Trends in Pharmacological Sciences, 34(9), 518–530. https://doi.org/10.1016/j.tips.201 3.07.003
Kim, Y. & Lim, H. H. (2021). Association of Early Pubertal Onset in Female Rats With Inhalation of Lavender Oil. Journal of Korean Medical Science, 37(2).
https://doi.org/10.3346/JKMS.2022.37.E9
Kolšek, K., Mavri, J., Dolenc, M. S., Gobec, S., & Turk, S. (2014). Endocrine disruptome–an open source prediction tool for assessing endocrine disruption potential through nuclear receptor binding. J. Chem. Inf. Model. 54: 1254–1267. https://doi.org/10.1021/ci400649p
Lemaire, G., Mnif, W., Mauvais, P., Balaguer, P., & Rahmani, R. (2006). Activation of α- and β-estrogen receptors by persistent pesticides in reporter cell lines. Life Sciences, 79(12), 1160–1169. https://doi.org/10.1016/j.lfs.2006.03.023
Lin, Y., Wang, Y., & Li, P. F. (2022). PPARα: An emerging target of metabolic syndrome, neurodegenerative and cardiovascular diseases. Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.1074911
Nappi, A., Murolo, M., Cicatiello A.G., A., Sagliocchi, S., Cicco, E. Di, Raia, M., Stornaiuolo, M., Dentice, M., & Miro, C. (2022). Thyroid Hormone Receptor Isoforms Alpha and Beta Play Convergent Roles in Muscle Physiology and Metabolic Regulation. Metabolites, 12(5), 405. https://doi.org/10.3390/metabo12050405
Nascimento, T., Gomes, D., Simões, R., & da Graça Miguel, M. (2023). Tea Tree Oil: Properties and the Therapeutic Approach to Acne—A Review. In Antioxidants, 12(6), 1264. https://doi.org/10.3390/antiox12061264
Nowak, K., & Jakopin, Ž. (2023). In silico profiling of endocrine-disrupting potential of bisphenol analogues and their halogenated transformation products. Food and Chemical Toxicology, 173. https://doi.org/10.1016/j.fct.2023.113623
Obr, A. E., & Edwards, D. P. (2012). The biology of progesterone receptor in the normal mammary gland and in breast cancer. Molecular and Cellular Endocrinology, 357(1), 4–17. https://doi.org/10.1016/j.mce.2011.10.030
Ramsey, J. T., Li, Y., Arao, Y., Naidu, A., Coons, L. A., Diaz, A., & Korach, K. S. (2019). Lavender products associated with premature thelarche and prepubertal gynecomastia: Case reports and EDC activities. J Clin Endocrinol Metab, 104(11), 5393-5405. https://doi.org/10.1210/jc.2018-01880/5544509
Sanajou, S., Ozkan, R.U., Erkekoglu, P., Girgin, G., & Baydar, T. (2024). Safety and possible risks of tea tree oil from a toxicological perspective. Istanbul Journal of Pharmacy, 54(3), 488-495. https://doi.org/10.26650/IstanbulJPharm.2024.1434421
Schneider, M., Pons, J. L., Labesse, G., & Bourguet, W. (2019). In silico predictions of endocrine disruptors properties. Endocrinology, 160(11), 2709–2716. https://doi.org/10.1210/en.2019-00382
Shao, M., Lu, L., Wang, Q., Ma, L., Tian, X., Li, C., Li, C., Guo, D., Wang, Q., Wang, W., & Wang, Y. (2021). The multi-faceted role of retinoid X receptor in cardiovascular diseases. Biomedicine and Pharmacotherapy, 137. https://doi.org/10.1016/j.biopha.2021.111264
Su, C., Huang, T., Zhang, M., Zhang, Y., Zeng, Y., & Chen, X. (2025). lucocorticoid receptor signaling in the brain and its involvement in cognitive function. Neural Regeneration Research, 20(9), 2520-2537. DOI: 10.4103/NRR.NRR-D-24-00355
Thuzar, M., & Stowasser, M. (2021). The mineralocorticoid receptor—an emerging player in metabolic syndrome? Journal of Human Hypertension, 35(2), 117–123. https://doi.org/10.1038/s41371-020-00467-3
Wang, X., Zhang, X., Xia, P., Zhang, J., Wang, Y., Zhang, R., Giesy, J. P., Shi, W., & Yu, H. (2017). A high-throughput, computational system to predict if environmental contaminants can bind to human nuclear receptors. Science of the Total Environment, 576, 609–616. https://doi.org/10.1016/j.scitotenv.2016.10.093
Yasin, M., Younis, A., Javed, T., Akram, A., Ahsan, M., Shabbir, R., Ali, M. M., Tahir, A., El-ballat, E. M., Sheteiwy, M. S., Sammour, R. H., Hano, C., Alhumaydhi, F. A., & El-Esawi, M. A. (2021). River tea tree oil: Composition, antimicrobial and antioxidant activities, and potential applications in agriculture. Plants, 10(10). https://doi.org/10.3390/plants10102105
License
Copyright (c) 2025 Selvira Anandia Intan Maulidya, Baiq Risky Wahyu Lisnasari, Indra Purnomo, Tuhfatul Ulya, Wayan Cintya Ganes Budastra

This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.